LS
STJ

Livforsakringsbolaget Skandia’s St Jude Medical STJ Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-27,867
Closed -$2.23K – 706
2016
Q4 		$2.23K Sell
27,867
-23,204
-45% -$1.84M 0.11% 197
2016
Q3 		$2.24M Buy
51,071
+12,904
+34% +$1.04M 0.11% 253
2016
Q2 		$2.98M Buy
38,167
+8,000
+27% +$570K 0.13% 179
2016
Q1 		$1.66M Hold
30,167
– – 0.08% 278
2015
Q4 		$1.86M Hold
30,167
– – 0.09% 247
2015
Q3 		$1.9M Hold
30,167
– – 0.1% 235
2015
Q2 		$2.2M Hold
30,167
– – 0.11% 213
2015
Q1 		$1.97M Hold
30,167
– – 0.1% 257
2014
Q4 		$1.96M Sell
30,167
-12,900
-30% -$831K 0.09% 256
2014
Q3 		$2.59M Hold
43,067
– – 0.1% 239
2014
Q2 		$2.98M Hold
43,067
– – 0.11% 210
2014
Q1 		$2.82M Buy
+43,067
New +$2.8M 0.11% 211

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Livforsakringsbolaget Skandia's STJ Position: Q1 2017 in Review

Livforsakringsbolaget Skandia sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 27,867 shares — an estimated $2.23K sold.

Livforsakringsbolaget Skandia first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $2.98M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Livforsakringsbolaget Skandia reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 27,867 St Jude Medical shares in Q1 2017, an estimated $2.23K.
  • Livforsakringsbolaget Skandia first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
  • Livforsakringsbolaget Skandia's St Jude Medical position peaked at $2.98M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2017, filed 26 Apr 2017.